Tag: Biosciences
Saluda Medical, developing world-first neuromodulation technologies, secures $10 million in new financing
SYDNEY, Australia /eNewsChannels/ -- NEWS: Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality. New investor Biosciences Managers led the funding round, in which existing investors also participated.
